AFRM vs ORKA · P/E 590, rev $3.22B vs $4.27B cap
Affirm Holdings Inc (AFRM) versus Oruka Therapeutics, Inc. (ORKA) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Oruka Therapeutics, Inc. (ORKA) is a biotechnology company listed on NASDAQ.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported ORKA revenue for 2024-06-30 was $0. Net income was -$22.2M. ORKA currently screens at market cap $4.27B.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. ORKA currently screens at market cap $4.27B.
Not investment advice. Open the AFRM and ORKA stock pages for the full models.
Not investment advice.